France· FR:69570312
MABELIO 500 mg, poudre pour solution à diluer pour solution pour perfusion
A medicinal product containing ceftobiprole médocaril sodique, registered in France by ADVANZ PHARMA LIMITED.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CEFTOBIPROLE MÉDOCARIL SODIQUE
- Manufacturer
- ADVANZ PHARMA LIMITED
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340092773166210 flacon(s) en verre de 20 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ceftobiprole médocaril sodique in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesZEVTERALa Jolla Pharmaceutical Company
- GermanyZevteraAdvanz Pharma Limited
- FinlandZevteraBasilea Pharmaceutica Deutschland GmbH
- BelgiumMabelio 500 mgBasilea Medical
- NorwayZevteraBasilea Pharmaceutica Deutschland GmbH
- SwedenZevtera 500 mg Pulver till koncentrat till infusionsvätska, lösningBasilea Pharmaceutica Deutschland GmbH
- IrelandAdaluzis 500mg Powder for concentrate for solution for infusionAdvanz Pharma Limited
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Zevtera
- Germany · Zevtera
- Denmark · Zevtera
- Spain · Zevtera
- Finland · Zevtera
- United Kingdom (Northern Ireland) · Zevtera
- Ireland · Adaluzis
- Italy · Mabelio
- Luxembourg · Mabelio, Zevtera
- Norway · Zevtera
- Poland · Zevtera
- Portugal · Zevtera
- Sweden · Zevtera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8e6a8717-e6a2-4290-83a2-4820395c8d88 GET /v1/drugs/8e6a8717-e6a2-4290-83a2-4820395c8d88?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69570312",
"date_amm": "2014-04-03",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "CEFTOBIPROLE MÉDOCARIL SODIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about ceftobiprole médocaril sodique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.